# US Depression Screening Mental Health Market > US Depression Screening Mental Health Market Research Report: By Indication (Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, Others), By Diagnosis (Psychological Tests, Blood Tests, Pharmacogenomic Testing, Others) and By End User (Hospitals and Clinics, Home-based, Research and Academic Institutes) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.87% - **2024:** $ 178.98 Million - **2025:** $ 189.48 Million - **2035:** $ 335.27 Million - **Key Players:** UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), CVS Health (US), Teladoc Health (US), Mental Health America (US), Lemonaid Health (US) **Report ID:** MRFR/Pharma/11780-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-depression-screening-mental-health-market-13305 --- ## Market Summary ## **US Depression Screening Mental Health Market Overview** **As per MRFR analysis, the US Depression Screening Mental Health Market Size was estimated at 168.93 (USD Million) in 2023. The US Depression Screening Mental Health Market Industry is expected to grow from 178.85(USD Million) in 2024 to 412 (USD Million) by 2035. The US Depression Screening Mental Health Market CAGR (growth rate) is expected to be around 7.881% during the forecast period (2025 - 2035).** ### **Key US Depression Screening Mental Health Market Trends Highlighted** The US Depression Screening Mental Health Market is experiencing notable trends driven by increasing awareness of mental health issues. There is a growing recognition of the importance of early screening and intervention for depression, leading to greater demand for innovative screening tools and methods among healthcare providers. A significant driver of this market is the rise in mental health concerns, exacerbated by recent global events which have intensified feelings of anxiety and depression among the population. The government's initiatives to improve mental health services, coupled with funding for mental health programs, are creating an environment conducive to the development and implementation of effective screening solutions. In recent times, telehealth services have gained momentum, providing accessible mental health screening options to individuals who may have previously faced barriers to seeking help. This shift towards digital health solutions presents opportunities for the integration of technological advancements such as artificial intelligence and mobile health applications, which can streamline the screening process and enhance user engagement. Additionally, increasing collaboration between healthcare practitioners, technology developers, and mental health organizations is fostering the development of comprehensive screening protocols that can be widely adopted across various healthcare settings. As public health campaigns continue to destigmatize mental illness, there is an opening for broader screening programs at schools, workplaces, and community centers in the US. These initiatives aim to increase awareness and facilitate timely identification of depression, aligning with the national goal of promoting mental well-being. Overall, the US [Depression Screening Mental Health](../../../reports/depression-screening-mental-health-market-3806) Market is evolving rapidly, with a clear shift towards proactive mental health strategies, creating a more supportive landscape for individuals seeking help. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Depression Screening Mental Health Market Drivers** ### **Increased Awareness of Mental Health Issues** There is a growing recognition of mental health issues in the United States, particularly depression. According to the National Institute of Mental Health, approximately 19.4% of adults in the US experienced a mental illness in 2019, representing over 47 million individuals. This growing awareness is fostering demand for depression screening tools and services, including those provided by established organizations like the American Psychological Association, which actively promotes mental health initiatives. Recommendations made by healthcare authorities, which suggest regular screening for depression in primary care settings, significantly drive the US Depression Screening Mental Health Market Industry. Furthermore, the implementation of initiatives such as the United States Preventive Services Task Force, which recommends that healthcare providers screen all adults for depression, enhances the adoption and utilization of mental health screening technologies, leading to market growth. ### **Integration of Technology in Mental Health Screening** The integration of technology, including telemedicine and artificial intelligence in mental health screening processes, is revolutionizing the US Depression Screening Mental Health Market Industry. The Health Resources and Services Administration noted a significant increase in telehealth services approved for mental health during the COVID-19 pandemic, showing a 154% increase in telehealth visits initially. Organizations like the American Telemedicine Association highlight that remote screening tools and platforms not only expand access to care but also improve patient outcomes. As technology transforms how mental health services are delivered, the reliance on digital platforms for depression screening continues to grow, thereby expanding market opportunities. ### **Policy Changes Supporting Mental Health Screening** Recent policy changes aimed at enhancing mental health services are crucial for the growth of the US Depression Screening Mental Health Market Industry. The 2020 Coronavirus Aid, Relief, and Economic Security Act noted a push for mental health screenings amidst the pandemic, reflecting increased governmental support for mental health initiatives. The National Alliance on Mental Illness reports that many states are now mandated to incorporate mental health screenings into their regular health assessments, effectively increasing demand for validated screening tools. These policy advancements underscore the need for robust screening processes, positively influencing market trajectories and creating an environment conducive to the development and deployment of innovative mental health solutions. ## **US Depression Screening Mental Health Market Segment Insights** ### **Depression Screening Mental Health Market Indication Insights** The US Depression Screening Mental Health Market is a critical sector addressing a significant public health concern. Within this market, the Indication segment encompasses various mental health conditions pivotal to understanding market dynamics. Major Depressive Disorder, a predominant category, has gained attention due to its high prevalence, affecting millions in the US annually. The recognition of anxiety distress, alongside major depressive disorder, underlines the growing complexity of mental health interrelations and the necessity for comprehensive screening protocols. Bipolar Disorder stands out due to its episodic nature, requiring specialized approaches for both diagnosis and management, contributing significantly to overall mental health strategies. Moreover, Psychotic Disorders pose unique challenges, necessitating tailored screening methods to ensure timely identification and treatment of affected individuals. The presence of various other mental health conditions further illustrates the diverse landscape within this market. The ongoing rise in mental health awareness is expected to fuel the demand for effective screening tools and methods. This evolution in understanding mental health opens opportunities for innovative solutions, improved patient outcomes, and a potential decrease in healthcare costs associated with untreated disorders. As such, the US Depression Screening Mental Health Market presents a landscape rich with potential for growth, driven by the continuous need for comprehensive mental health care and screening initiatives. The insights generated from understanding the segmentation of not just these indicators but the holistic view of mental health challenges underscore the market’s importance within the healthcare ecosystem, reflecting broader societal trends and the increasing prioritization of mental well-being. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Depression Screening Mental Health Market Diagnosis Insights** The Diagnosis segment of the US Depression Screening Mental Health Market holds significant importance as it provides essential tools for identifying and managing depression. Psychological tests are widely used due to their ability to assess mental health conditions through standardized questionnaires and interviews, offering critical insights into a person's emotional and psychological state. Blood tests are gaining traction as emerging research reveals potential biomarkers related to depression, allowing for more objective diagnosis. Pharmacogenomic testing is becoming increasingly relevant, as it helps tailor medication approaches by examining how an individual's genetic makeup affects their response to antidepressants, improving treatment efficacy. Additionally, the category labeled as 'Others' encompasses various diagnostic methodologies, which increasingly focus on technological advancements and holistic approaches in understanding mental health. Overall, the segmentation within the Diagnosis area reveals a diversified landscape aimed at enhancing depression diagnosis solutions within the US, addressing the rising prevalence of mental health issues and the demand for precise diagnostic tools in clinical settings. ### **Depression Screening Mental Health Market End User Insights** The US Depression Screening Mental Health Market encompasses various End User categories, notably Hospitals and Clinics, Home-based settings, and Research and Academic Institutes, each playing a crucial role in addressing the mental health challenges associated with depression. Hospitals and Clinics often lead in implementing comprehensive screening procedures, serving as critical touchpoints for patients seeking diagnosis and treatment, thereby significantly contributing to market growth. Home-based solutions continue to gain traction, fueled by advancements in technology and the rising preference for remote healthcare, which allows for personalized mental health support, making it an essential component of the market. Meanwhile, Research and Academic Institutes are pivotal for developing innovative screening tools and methodologies, ensuring rapid advancements in understanding depression and enhancing patient outcomes. These segments are paramount as they align with the increasing awareness and urgency surrounding mental health, thereby driving the US Depression Screening Mental Health Market forward, as evidenced by rising initiatives and funding measures from national health organizations aimed at improving mental health services across the nation. ## **US Depression Screening Mental Health Market Key Players and Competitive Insights** The US Depression Screening Mental Health Market has become increasingly competitive as mental health awareness and the need for effective screening processes grow. Various stakeholders, including healthcare providers, technology companies, and mental health organizations, are vying for dominance in a landscape that is expanding rapidly due to heightened public awareness of mental health issues. As mental health problems become more prevalent, the demand for reliable and accessible screening tools and services has surged. Innovations in technology, particularly telemedicine and digital mental health solutions, are playing a pivotal role in shaping the market dynamics. Companies are investing in research and development to improve screening methodologies, ensure regulatory compliance, and increase patient engagement. Overall, the competitive insights within this market reflect a vibrant ecosystem aimed at enhancing mental health outcomes across the nation. ### **American Well** American Well stands out in the US Depression Screening Mental Health Market due to its robust telehealth platform, which seamlessly integrates mental health services into broader healthcare offerings. The company's strengths lie in its established reputation as a trusted provider of telehealth solutions, making mental health screenings accessible to a wider audience. American Well employs a data-driven approach to ensure that its screening tools meet clinical standards while being easy to use for patients. With partnerships across various healthcare providers and insurers, the company has created a significant market presence, enabling it to cater to diverse patient populations. The ability to offer comprehensive mental health services through its integrated platform enhances the user experience and positions American Well favorably in the competitive landscape. ### **Talkspace** Talkspace has carved out a distinctive niche within the US Depression Screening Mental Health Market by focusing primarily on providing accessible online therapy and mental health support. With a user-friendly platform that connects clients with licensed therapists, the company has made significant strides in democratizing mental health services. Talkspace's strengths include a diverse range of offerings such as personalized therapy sessions, text-based communication, and video therapy options, catering to different preferences and lifestyles. By leveraging technology, Talkspace provides flexible solutions to those seeking depression screenings and ongoing mental health support. As the company continues to expand its services and product offerings, including potential mergers and acquisitions aimed at enhancing its capabilities, it remains a formidable competitor in the US market. This strategic positioning allows Talkspace to serve a larger demographic effectively, making it a noteworthy player in the mental health sector focused on depression screening. ### **Key Companies in the US Depression Screening Mental Health Market Include** ## **US Depression Screening Mental Health Market Industry Developments** The US Depression Screening Mental Health Market has recently seen notable developments. American Well continues expanding its virtual care services, reflecting a growing trend towards telehealth solutions. In October 2023, Talkspace announced enhancements to its platform, focusing on personalized therapy options, an area of rising demand. MDLIVE reported an increase in user engagement, underlining the effectiveness of remote mental health services. In terms of acquisitions, in August 2023, BetterHelp acquired the digital therapy platform offered by a leading competitor, enhancing its service offerings and market reach. Pear Therapeutics launched new initiatives aimed at integrating digital therapeutics with traditional therapy for enhanced patient outcomes. The overall market is experiencing growth, with estimates from governmental health agencies suggesting a significant uptick in demand for mental health services, driven by increased awareness and the ongoing impact of the COVID-19 pandemic. Companies like Lyra Health, Calm, and Spring Health remain prominent as they innovate to meet the needs of users seeking mental health support. The combination of innovative technology, strategic mergers, and heightened demand is shaping the landscape of the US Depression Screening Mental Health Market. ## **US Depression Screening Mental Health Market Segmentation Insights** ### **Depression Screening Mental Health Market Indication Outlook** ### **Depression Screening Mental Health Market Diagnosis Outlook** ### **Depression Screening Mental Health Market End User Outlook** - Hospitals and Clinics - Home-based - Research and Academic Institutes ## Market Drivers ### Policy and Regulatory Support Government policies and regulations play a pivotal role in shaping the depression screening-mental-health market. Recent legislative efforts have focused on enhancing mental health services, including the integration of depression screening into primary care settings. The Mental Health Parity and Addiction Equity Act mandates that mental health services be covered by insurance plans, which may lead to increased access to screening. Furthermore, the Centers for Medicare & Medicaid Services have introduced reimbursement codes for depression screening, incentivizing healthcare providers to adopt these practices. This regulatory support is expected to drive market growth, as more individuals gain access to necessary screening services, ultimately improving mental health outcomes across the population. ### Rising Prevalence of Depression The increasing prevalence of depression in the US is a critical driver for the depression screening market. Recent studies indicate that approximately 8.4% of adults experience major depressive episodes annually. This rising trend necessitates effective screening methods to identify individuals in need of mental health support. As awareness grows, healthcare providers are more likely to implement standardized screening protocols, thereby expanding the market. The National Institute of Mental Health reports that untreated depression can lead to significant economic burdens, estimated at over $210 billion annually in lost productivity and healthcare costs. Consequently, the demand for effective screening tools and interventions is likely to increase, propelling growth in the depression screening-mental-health market. ### Increased Collaboration Among Stakeholders Collaboration among various stakeholders, including healthcare providers, insurers, and community organizations, is driving the depression screening-mental-health market. This collaborative approach aims to create comprehensive mental health care systems that prioritize early detection and intervention. Partnerships between public health agencies and private organizations are facilitating the development of community-based screening programs, which are essential for reaching underserved populations. The Substance Abuse and Mental Health Services Administration emphasizes the importance of such collaborations in improving access to mental health services. As these partnerships expand, the market is likely to benefit from increased awareness, resources, and support for depression screening initiatives. ### Growing Focus on Mental Health in Education The emphasis on mental health within educational institutions is emerging as a significant driver for the depression screening-mental-health market. Schools and universities are increasingly recognizing the importance of mental health support for students. Initiatives aimed at implementing mental health screenings in educational settings are becoming more common, with many institutions adopting programs to identify and assist students experiencing depression. The National Alliance on Mental Illness reports that 1 in 5 youth experience a mental health condition, highlighting the need for early intervention. By integrating screening into educational frameworks, the market is likely to see growth as more young individuals receive the necessary support and resources to address their mental health needs. ### Technological Advancements in Screening Tools Technological advancements are transforming the landscape of the depression screening-mental-health market. Innovations such as digital screening tools, mobile applications, and telehealth services are making it easier for individuals to access mental health assessments. For instance, the use of artificial intelligence in developing predictive algorithms for depression screening is gaining traction. These tools can analyze patient data more efficiently, leading to quicker and more accurate diagnoses. The integration of technology not only enhances the screening process but also encourages individuals to seek help, thereby expanding the market. As the demand for convenient and accessible mental health solutions grows, the adoption of these advanced screening tools is likely to increase. ## Future Outlook The [Depression Screening Mental Health Market](https://www.marketresearchfuture.com/reports/depression-screening-mental-health-market-3806) is projected to grow at a 5.87% CAGR from 2025 to 2035, driven by increasing awareness and technological advancements. **New opportunities:** - Integration of AI-driven diagnostic tools for personalized treatment plans. - Expansion of telehealth services to reach underserved populations. - Development of subscription-based mental health support platforms. By 2035, the market is expected to be robust, reflecting significant advancements and increased accessibility. ## Segment Insights ### By Indication: Major Depressive Disorder (Largest) vs. Anxiety Distress (Fastest-Growing) In the US depression screening-mental-health market, Major Depressive Disorder holds the largest share among different indication values, indicating a significant prevalence and demand for targeted screening methods. Anxiety Distress also demonstrates notable traction, suggesting that while Major Depressive Disorder remains central, growing awareness and screening efforts for anxiety-related conditions are gaining ground. Growth trends within this segment highlight a rise in mental health awareness, increased stigma reduction, and greater accessibility to mental health resources. Major Depressive Disorder continues to dominate due to its widespread recognition, but Anxiety Distress is rapidly emerging, encouraged by initiatives aimed at addressing anxiety as a critical mental health concern. This shift is driving innovation in screening tools and treatment options tailored for these conditions. Major Depressive Disorder (Dominant) vs. Anxiety Distress (Emerging) Major Depressive Disorder, as the dominant indication within the US depression screening-mental-health market, is characterized by its profound impact on individuals and the healthcare system. It is often prioritized in screenings due to its high prevalence and serious consequences if left untreated. Meanwhile, Anxiety Distress is gaining prominence as an emerging indication, driven by increased recognition of its correlation with Major Depressive Disorder. The rise in dual diagnoses presents both challenges and opportunities for mental health providers. Innovations in screening techniques, combined with the growing focus on holistic mental health, are likely to enhance service delivery and improve outcomes across these indications. ### By Diagnosis: Psychological Tests (Largest) vs. Blood Tests (Fastest-Growing) In the US depression screening-mental-health market, Psychological Tests dominate with a significant share, reflecting their established role in diagnosing mental health disorders. Blood Tests have been gaining traction, appealing to those looking for biological markers to aid in diagnoses and treatment plans, contributing to a competitive landscape amid rising awareness of mental health issues. Growth trends in this segment are fueled by increasing investments in mental health technologies and a push for personalized approaches to treatment. The adoption of Blood Tests, noted for their advancements in pharmacogenomics, is particularly significant, enabling tailored treatment plans based on individual biological responses. This reflects a broader shift towards integrated care methods, enhancing diagnostic processes for mental health practitioners. Psychological Tests: Dominant vs. Blood Tests: Emerging Psychological Tests represent the dominant segment in the US depression screening-mental-health market, primarily due to their long-standing application in assessing mood disorders and providing structured evaluations. These tests typically encompass a range of standardized questionnaires and assessments, aiding clinicians in diagnosing complex mental health issues. Conversely, Blood Tests are emerging as a viable alternative, appealing to a demographic seeking more scientifically grounded methods of diagnosis. Blood Tests leverage advancements in pharmacogenomic research to predict patient responses to certain antidepressants, thereby fostering a personalized treatment approach. This adaptability is critical as patients and healthcare providers increasingly seek testing methods that offer clear insights into treatment efficacy and potential side effects. ### By End User: Hospitals and Clinics (Largest) vs. Home-based (Fastest-Growing) In the US depression screening-mental-health market, hospitals and clinics hold the largest share, demonstrating a robust infrastructure for mental health services. These institutions are often the first point of contact for individuals seeking help, equipped with trained professionals and resources that cater to various mental health needs. Home-based services, on the other hand, are rapidly gaining traction due to the increasing preference for convenience and privacy. Patients appreciate the flexibility that home-based screening provides, leading to a significant shift in patient engagement strategies. The growth trends in the end user segment are heavily influenced by technological advancements and a greater public awareness of mental health issues. Hospitals and clinics are adapting to integrate digital screening tools, enhancing accessibility for patients. Meanwhile, the home-based services are being driven by teletherapy and digitalization, which empower patients to manage their mental health from the comfort of their homes. Research and academic institutes contribute through studies that advance screening techniques, further propelling innovation in the sector. Hospitals and Clinics (Dominant) vs. Home-based (Emerging) Hospitals and clinics serve as the dominant force in the US depression screening-mental-health market, leveraging established protocols and a wide array of medical professionals. Their integrated approach, combining psychological evaluation with medical assessment, ensures comprehensive care for those suffering from mental health issues. As they continue to invest in advanced technologies and training, hospitals and clinics are positioned to maintain their leadership role. Conversely, home-based services are emerging, driven by the growing desire for personalized care and the sense of safety provided by home environments. This segment's flexibility, combined with the rise in telehealth applications, enables it to cater effectively to a broader audience, including those hesitant to seek traditional in-clinic services. ## Competitive Benchmarking The depression screening market in the US is characterized by a dynamic competitive landscape, driven by increasing awareness of mental health issues and the growing demand for accessible screening solutions. Major players such as UnitedHealth Group (US), Anthem (US), and Teladoc Health (US) are strategically positioned to leverage digital transformation and innovative service delivery models. UnitedHealth Group (US) focuses on integrating behavioral health services into its broader health plans, enhancing patient access and care coordination. Meanwhile, Anthem (US) emphasizes partnerships with technology firms to expand its telehealth offerings, thereby improving patient engagement and outcomes. Teladoc Health (US) continues to innovate through its virtual care platform, which integrates mental health services with primary care, reflecting a holistic approach to health management. Collectively, these strategies contribute to a competitive environment that prioritizes accessibility, integration, and patient-centric care.The market structure appears moderately fragmented, with a mix of large insurers and specialized mental health service providers. Key players are employing various business tactics, such as optimizing their supply chains and localizing service delivery to enhance responsiveness to patient needs. This fragmentation allows for diverse service offerings, yet the influence of major players remains significant, as they set standards for quality and accessibility in mental health care. In October UnitedHealth Group (US) announced a partnership with a leading telehealth platform to enhance its mental health screening capabilities. This strategic move is likely to bolster its service offerings, allowing for more comprehensive mental health assessments and timely interventions. By integrating advanced telehealth solutions, UnitedHealth Group (US) aims to improve patient outcomes and streamline care delivery, positioning itself as a leader in the mental health space. In September Anthem (US) launched a new initiative aimed at expanding access to mental health services through community-based programs. This initiative is significant as it reflects a commitment to addressing mental health disparities, particularly in underserved populations. By focusing on community engagement and local partnerships, Anthem (US) is likely to enhance its brand reputation and foster loyalty among its members, while also contributing to broader public health goals. In August Teladoc Health (US) introduced an AI-driven mental health assessment tool designed to provide personalized care recommendations. This innovation underscores the growing trend of integrating artificial intelligence into mental health services, potentially improving the accuracy and efficiency of screenings. As AI continues to evolve, Teladoc Health (US) is well-positioned to capitalize on this technology, enhancing its competitive edge in the market. As of November current trends in the depression screening-mental-health market include a pronounced shift towards digitalization and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing service delivery. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, quality of care, and supply chain reliability. This shift suggests that companies that prioritize innovation and patient-centric solutions will be better positioned to thrive in the increasingly complex mental health market. ## Recent News & Developments The US Depression Screening Mental Health Market has recently seen notable developments. American Well continues expanding its virtual care services, reflecting a growing trend towards telehealth solutions. In October 2023, Talkspace announced enhancements to its platform, focusing on personalized therapy options, an area of rising demand. MDLIVE reported an increase in user engagement, underlining the effectiveness of remote mental health services. In terms of acquisitions, in August 2023, BetterHelp acquired the digital therapy platform offered by a leading competitor, enhancing its service offerings and market reach. Pear Therapeutics launched new initiatives aimed at integrating digital therapeutics with traditional therapy for enhanced patient outcomes. The overall market is experiencing growth, with estimates from governmental health agencies suggesting a significant uptick in demand for mental health services, driven by increased awareness and the ongoing impact of the COVID-19 pandemic. Companies like Lyra Health, Calm, and Spring Health remain prominent as they innovate to meet the needs of users seeking mental health support. The combination of innovative technology, strategic mergers, and heightened demand is shaping the landscape of the US Depression Screening Mental Health Market. ## Report Scope | MARKET SIZE 2024 | 178.98(USD Million) | | --- | --- | | MARKET SIZE 2025 | 189.48(USD Million) | | MARKET SIZE 2035 | 335.27(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.87% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), CVS Health (US), Teladoc Health (US), Mental Health America (US), Lemonaid Health (US) | | Segments Covered | Indication, Diagnosis, End User | | Key Market Opportunities | Integration of digital health solutions enhances accessibility and efficiency in the depression screening-mental-health market. | | Key Market Dynamics | Rising demand for digital screening tools drives innovation and competition in the depression screening-mental-health market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US depression screening-mental-health market in 2024?** A: The market valuation was $178.98 Million in 2024. **Q: What is the projected market valuation for the US depression screening-mental-health market by 2035?** A: The projected valuation for 2035 is $335.27 Million. **Q: What is the expected CAGR for the US depression screening-mental-health market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 5.87%. **Q: Which key players are leading the US depression screening-mental-health market?** A: Key players include UnitedHealth Group, Anthem, Cigna, Kaiser Permanente, CVS Health, Teladoc Health, Mental Health America, and Lemonaid Health. **Q: What are the major segments of the US depression screening-mental-health market?** A: Major segments include Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, and Others. **Q: What was the valuation range for Major Depressive Disorder in 2024?** A: The valuation range for Major Depressive Disorder was $70.0 Million to $130.0 Million. **Q: How much is the market for psychological tests valued in 2024?** A: The market for psychological tests was valued between $70.0 Million and $130.0 Million. **Q: What is the expected valuation range for home-based services in the US depression screening-mental-health market?** A: The expected valuation range for home-based services is $50.0 Million to $100.0 Million. **Q: What segment had a valuation of $20.0 Million to $40.0 Million in 2024?** A: Psychotic Disorders had a valuation range of $20.0 Million to $40.0 Million. **Q: What is the projected growth trend for the US depression screening-mental-health market?** A: The market appears to be on a growth trend, projected to reach $335.27 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-depression-screening-mental-health-market-13305*